Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere Shortening | 2 | 2021 | 36 | 0.800 |
Why?
|
| Sirtuins | 1 | 2019 | 16 | 0.630 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 934 | 0.480 |
Why?
|
| Mitochondria | 4 | 2017 | 737 | 0.410 |
Why?
|
| Telomere | 3 | 2021 | 230 | 0.400 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 195 | 0.360 |
Why?
|
| Telomerase | 3 | 2019 | 179 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 789 | 0.290 |
Why?
|
| Chromatin | 2 | 2022 | 606 | 0.290 |
Why?
|
| Aging | 2 | 2012 | 1303 | 0.280 |
Why?
|
| Telomere Homeostasis | 2 | 2019 | 47 | 0.250 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 47 | 0.210 |
Why?
|
| Collagen Type VI | 1 | 2021 | 7 | 0.190 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 26 | 0.190 |
Why?
|
| Protein Subunits | 1 | 2021 | 174 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 139 | 0.180 |
Why?
|
| Cullin Proteins | 1 | 2020 | 15 | 0.170 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 200 | 0.170 |
Why?
|
| Hematopoiesis | 1 | 2021 | 228 | 0.160 |
Why?
|
| Fibrosis | 1 | 2021 | 464 | 0.160 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 5 | 0.160 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 34 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 216 | 0.150 |
Why?
|
| Claudins | 1 | 2018 | 31 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 52 | 0.150 |
Why?
|
| Muscle Proteins | 2 | 2018 | 423 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2021 | 3161 | 0.150 |
Why?
|
| Mitosis | 1 | 2018 | 193 | 0.150 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2011 | 166 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 258 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 861 | 0.140 |
Why?
|
| Glioblastoma | 2 | 2012 | 373 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 248 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 464 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 714 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 58 | 0.130 |
Why?
|
| Animals | 14 | 2021 | 36266 | 0.130 |
Why?
|
| Cell Movement | 2 | 2018 | 916 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2019 | 805 | 0.130 |
Why?
|
| Mice | 11 | 2021 | 18808 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4786 | 0.120 |
Why?
|
| Signal Transduction | 7 | 2021 | 4879 | 0.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 240 | 0.120 |
Why?
|
| p21-Activated Kinases | 2 | 2018 | 58 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 2111 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 733 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 608 | 0.100 |
Why?
|
| Genes, Essential | 1 | 2012 | 42 | 0.100 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 2159 | 0.090 |
Why?
|
| Genes, myc | 2 | 2022 | 107 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 1850 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3956 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2017 | 861 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 1051 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2012 | 538 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 196 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 155 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 407 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 395 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 222 | 0.080 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 21 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2537 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2011 | 473 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 563 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2020 | 2701 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 70 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 643 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2008 | 13 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2017 | 400 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2018 | 772 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 420 | 0.070 |
Why?
|
| Carcinogens | 1 | 2008 | 159 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1531 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 522 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 133540 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2010 | 2023 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2766 | 0.060 |
Why?
|
| Stem Cells | 1 | 2010 | 749 | 0.060 |
Why?
|
| Cyclophilin A | 1 | 2024 | 15 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1334 | 0.050 |
Why?
|
| Mutation | 1 | 2017 | 6260 | 0.050 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 64 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3719 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1400 | 0.050 |
Why?
|
| Apoptosis | 2 | 2021 | 1929 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2021 | 139 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 50 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 269 | 0.050 |
Why?
|
| Megakaryocytes | 1 | 2021 | 45 | 0.050 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 185 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 145 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 906 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 134 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 179 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2020 | 147 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 190 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 452 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 509 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 27 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 27 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 71 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 39 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2020 | 827 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 70 | 0.040 |
Why?
|
| Phenotype | 3 | 2017 | 4523 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 664 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 348 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 194 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 382 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2020 | 687 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 384 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 823 | 0.030 |
Why?
|
| DNA Damage | 2 | 2011 | 542 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Proteogenomics | 1 | 2018 | 102 | 0.030 |
Why?
|
| Male | 3 | 2019 | 65774 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1793 | 0.030 |
Why?
|
| Female | 3 | 2019 | 71524 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 129 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1831 | 0.030 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 266 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2017 | 254 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1753 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1698 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 3876 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 586 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 867 | 0.030 |
Why?
|
| Phosphonoacetic Acid | 1 | 2012 | 2 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 31 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 64 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2012 | 25 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 152 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 1145 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 1848 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 397 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 103 | 0.020 |
Why?
|
| Cardiac Volume | 1 | 2011 | 22 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1061 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 224 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 42 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 68 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2012 | 65 | 0.020 |
Why?
|
| Chloroquine | 1 | 2011 | 32 | 0.020 |
Why?
|
| Enzyme Reactivators | 1 | 2010 | 3 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 113 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 156 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 37 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 560 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 273 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 59 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 710 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 451 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 271 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 126 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 468 | 0.020 |
Why?
|
| Smell | 1 | 2010 | 131 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 644 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 605 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2010 | 152 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 536 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 376 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 169 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 480 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 55 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 86 | 0.020 |
Why?
|
| Epidermis | 1 | 2008 | 67 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 694 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 795 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 177 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 508 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1711 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 1668 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3471 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 3211 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 3007 | 0.010 |
Why?
|